Omega-3 fatty acids and cancer cell cytotoxicity: Implications for multi-targeted cancer therapy

Journal of Clinical Medicine

Volumn 5, Issue 2, 2016, Pages

  D’Eliseo, Donatella ^a,b   Velotti, Francesca ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Apoptosis; Cancer stem cells; Cancer therapy; Combinational therapy; Cytotoxicity; Docosahexaenoic acid (DHA); Drug resistance; Eicosapentaenoic acid (EPA); Fatty acids (FAs); N 3 polyunsaturated fatty acids (PUFAs)

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BETA CATENIN; CASPASE 10; CASPASE 8; OMEGA 3 FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROCASPASE 8; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; WNT PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CANCER THERAPY; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOTOXICITY; DIGESTIVE SYSTEM CANCER; DOWN REGULATION; ENDOPLASMIC RETICULUM; INFLAMMATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NEOPLASM; NON SMALL CELL LUNG CANCER; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION;

EID: 85114283834     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm5020015     Document Type: Article

References (167)

1. Ma, X.; Yu, H. Global burden of cancer. J. Biol. Med. 2006, 79, 85-94.
2. Basile, K.J.; Aplin, A.E. Resistance to chemotherapy: Short-term drug tolerance and stem cell-like subpopulations. Adv. Pharmacol. 2012, 65, 315-334. [PubMed]
3. Reya, T.; Morrison, S.J.; Clarke, M.F.;Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105-111. [CrossRef] [PubMed]
4. Maugeri-Saccà, M.; Vigneri, P.; de Maria, R. Cancer stem cells and chemosensitivity. Clin. Cancer Res. 2011, 17, 4942-4947. [CrossRef] [PubMed]
5. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674. [CrossRef] [PubMed]
6. Pritchard, J.R.; Bruno, P.M.; Gilbert, L.A.; Capron, K.L.; Lauffenburger, D.A.; Hemann, M.T. Defining principles of combination drug mechanisms of action. Proc. Natl. Acad. Sci. USA 2013, 110, E170-E179. [CrossRef] [PubMed]
7. Burlingame, B.; Nishida, C.; Uauy, R.; Weisell, R. Fats and fatty acids in human nutrition: Introduction. Ann. Nutr. Metable 2009, 55, 5-7. [CrossRef] [PubMed]
8. Riediger, N.D.; Othman, R.A.; Suh, M.; Moghadasian, M.H. A systemic review of the roles of n-3 fatty acids in health and disease. J. Am. Diet. Assoc. 2009, 109, 668-679. [CrossRef] [PubMed]
9. Calder, P.C. Marine ω-3 Fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta 2015, 1851, 469-484. [CrossRef] [PubMed]
10. Gil, A.; Gil, F. Fish, a Mediterranean source of n-3 PUFA: Benefits do not justify limiting consumption. Br. J. Nutr. 2015, 113, S58-S67. [CrossRef] [PubMed]
11. Laviano, A.; Rianda, S.; Molfino, A.; Rossi Fanelli, F. ω-3 Fatty acids in cancer. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 156-161. [CrossRef] [PubMed]
12. Bhagat, U.; Das, U.N. Potential role of dietary lipids in the prophylaxis of some clinical conditions. Arch. Med. Sci. 2015, 11, 807-818. [CrossRef] [PubMed]
13. Murray, M.; Hraiki, A.; Bebawy, M.; Pazderka, C.; Rawling, T. Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs. Pharmacol. Ther. 2015, 150, 109-128. [CrossRef] [PubMed]
14. Bang, H.O.; Dyerberg, J.; Nielsen, A.B. Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet 1971, 1, 1143-1145. [CrossRef]
15. Gu, Z.; Shan, K.; Chen, H.; Chen, Y.Q. n-3 Polyunsaturated fatty acids and their role in cancer chemoprevention. Curr. Pharmacol. Rep. 2015, 5, 283-294. [CrossRef] [PubMed]
16. Serini, S.; Fasano, E.; Piccioni, E.; Cittadini, A.R.; Calviello, G. Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects. Chem. Res. Toxicol. 2011, 24, 2093-2105. [CrossRef] [PubMed]
17. Chapkin, R.S.; DeClercq, V.; Kim, E.; Fuentes, N.R.; Fan, Y.Y. Mechanisms by which pleiotropic amphiphilic n-3 PUFA reduce colon cancer risk. Curr. Colorectal Cancer Rep. 2014, 10, 442-452. [CrossRef] [PubMed]
18. Kiyabu, G.Y.; Inoue, M.; Saito, E.; Abe, S.K.; Sawada, N.; Ishihara, J.; Iwasaki, M.; Yamaji, T.; Shimazu, T.; et al. JPHC Study Group. Fish, n-3 polyunsaturated fatty acids and n-6 polyunsaturated fatty acids intake and breast cancer risk: The Japan Public Health Center-based prospective study. Int. J. Cancer. 2015, 137, 2915-2926. [CrossRef] [PubMed]
19. Brasky, T.M.; Darke, A.K.; Song, X.; Tangen, C.M.; Goodman, P.J.; Thompson, I.M.; Meyskens, F.L., Jr.; Goodman, G.E.; Minasian, L.M.; et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J. Natl. Cancer Inst. 2013, 105, 1132-1141. [CrossRef] [PubMed]
20. Calder, P.C.; Deckelbaum, R.J. Dietary fatty acids in health and disease: Greater controversy, greater interest. Curr. Opin. Clin. Nutr. Metab. Care 2014, 17, 111-115. [CrossRef] [PubMed]
21. Weylandt, K.H.; Serini, S.; Chen, Y.Q.; Su, H.M.; Lim, K.; Cittadini, A.; Calviello, G. ω-3 Polyunsaturated fatty acids: The way forward in times of mixed evidence. Biomed. Res. Int. 2015, 2015, 143109. [CrossRef] [PubMed]
22. Berquin, I.M.; Edwards, I.J.; Chen, Y.Q. Multi-targeted therapy of cancer by ω-3 Fatty acids. Cancer Lett. 2008, 269, 363-377. [CrossRef] [PubMed]
23. Serini, S.; Piccioni, E.; Merendino, N.; Calviello, G. Dietary polyunsaturated fatty acids as inducers of apoptosis: Implications for cancer. Apoptosis 2009, 14, 132-152. [CrossRef] [PubMed]
24. Gleissman, H.; Johnsen, J.I.; Kogner, P. ω-3 Fatty acids in cancer, the protectors of good and the killers of evil? Exp. Cell Res. 2010, 316, 1365-1373. [CrossRef] [PubMed]
25. Vaughan, V.C.; Hassing, M.R.; Lewandowski, P.A. Marine polyunsaturated fatty acids and cancer therapy. Br. J. Cancer 2013, 108, 486-492. [CrossRef] [PubMed]
26. Biondo, P.D.; Brindley, D.N.; Sawyer, M.B.; Field, C.J. The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J. Nutr. Biochem. 2008, 19, 787-796. [CrossRef] [PubMed]
27. Siddiqui, R.A.; Harvey, K.A.; Xu, Z.; Bammerlin, E.M.; Walker, C.; Altenburg, J.D. Docosahexaenoic acid: A natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. Biofactors 2011, 37, 399-412. [CrossRef] [PubMed]
28. Wang, J.; Luo, T.; Li, S.; Zhao, J. The powerful applications of polyunsaturated fatty acids in improving the therapeutic efficacy of anticancer drugs. Expert Opin. Drug Deliv. 2012, 9, 1-7. [CrossRef] [PubMed]
29. Merendino, N.; Costantini, L.; Manzi, L.; Molinari, R.; D'Eliseo, D.; Velotti, F. Dietary ω -3 polyunsaturated fatty acid DHA: A potential adjuvant in the treatment of cancer. Biomed. Res. Int. 2013, 2013, 310186. [CrossRef] [PubMed]
30. Hajjaji, N.; Bougnoux, P. Selective sensitization of tumors to chemotherapy by marine-derived lipids: A review. Cancer Treat. Rev. 2013, 39, 473-488. [CrossRef] [PubMed]
31. de Aguiar Pastore Silva, J.; Emilia de Souza Fabre, M.; Waitzberg, D.L. ω-3 Supplements for patients in chemotherapy and/or radiotherapy: A systematic review. Clin. Nutr. 2015, 34, 359-366. [CrossRef] [PubMed]
32. Das, U.N.; Madhavi, N.; Sravan Kumar, G.; Padma, M.; Sangeetha, P. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukot. Essent. Fatty Acids 1998, 58, 39-54. [CrossRef]
33. Slagsvold, J.E.; Pettersen, C.H.; Størvold, G.L.; Follestad, T.; Krokan, H.E.; Schønberg, S.A. DHA alters expression of target proteins of cancer therapy in chemotherapy resistant SW620 colon cancer cells. Nutr. Cancer 2010, 62, 611-621. [CrossRef] [PubMed]
34. Kuan, C.Y.;Walker, T.H.; Luo, P.G.; Chen, C.F. Long-chain polyunsaturated fatty acids promote paclitaxel cytotoxicity via inhibition of the MDR1 gene in the human colon cancer Caco-2 cell line. J. Am. Coll. Nutr. 2011, 30, 265-273. [CrossRef] [PubMed]
35. Gelsomino, G.; Corsetto, P.A.; Campia, I.; Montorfano, G.; Kopecka, J.; Castella, B.; Gazzano, E.; Ghigo, D.; Rizzo, A.M.; Riganti, C. ω 3 Fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Mol. Cancer 2013, 12, 137. [CrossRef] [PubMed]
36. Das, U.N.; Begin, M.E.; Ells, G.; Huang, Y.S.; Horrobin, D.F. Polyunsaturated fatty acids augment free radical generation in tumor cells in vitro. Biochem. Biophys. Res. Commun. 1987, 145, 15-24. [CrossRef]
37. Tsai, W.S.; Nagawa, H.; Kaizaki, S.; Tsuruo, T.; Muto, T. Inhibitory effects of n--3 polyunsaturated fatty acids on sigmoid colon cancer transformants. J. Gastroenterol. 1998, 33, 206-212. [CrossRef] [PubMed]
38. Siddiqui, R.A.; Harvey, K.; Stillwell, W. Anticancer properties of oxidation products of docosahexaenoic acid. Chem. Phys. Lipids 2008, 153, 47-56. [CrossRef] [PubMed]
39. Giros, A.; Grzybowski, M.; Sohn, V.R.; Pons, E.; Fernandez-Morales, J.; Xicola, R.M.; Sethi, P.; Grzybowski, J.; Goel, A.; et al. Regulation of colorectal cancer cell apoptosis by the n-3 polyunsaturated fatty acids Docosahexaenoic and Eicosapentaenoic. Cancer Prev. Res. 2009, 2, 732-742. [CrossRef] [PubMed]
40. Toit-Kohn, J.L.; Louw, L.; Engelbrecht, A.M. Docosahexaenoic acid induces apoptosis in colorectal carcinoma cells by modulating the PI3 kinase and p38 MAPK pathways. J. Nutr. Biochem. 2009, 20, 106-114. [CrossRef] [PubMed]
41. Gleissman, H.; Segerström, L.; Hamberg, M.; Ponthan, F.; Lindskog, M.; Johnsen, J.I.; Kogner, P. ω-3 Fatty acid supplementation delays the progression of neuroblastoma in vivo. Int. J. Cancer 2011, 128, 1703-1711. [CrossRef] [PubMed]
42. Nikolakopoulou, Z.; Nteliopoulos, G.; Michael-Titus, A.T.; Parkinson, E.K. ω-3 Polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2. Carcinogenesis 2013, 34, 2716-2725. [CrossRef] [PubMed]
43. Ravacci, G.R.; Brentani, M.M.; Tortelli, T.Jr.; Torrinhas, R.S.; Saldanha, T.; Torres, E.A.; Waitzberg, D.L. Lipid raft disruption by docosahexaenoic acid induces apoptosis in transformed human mammary luminal epithelial cells harboring HER-2 overexpression. J. Nutr. Biochem. 2013, 24, 505-515. [CrossRef] [PubMed]
44. Abdi, J.; Garssen, J.; Faber, J.; Redegeld, F.A. ω-3 Fatty acids, EPA and DHA induce apoptosis and enhance drug sensitivity in multiple myeloma cells but not in normal peripheral mononuclear cells. J. Nutr. Biochem. 2014, 25, 1254-1262. [CrossRef] [PubMed]
45. Berstad, P.; Thiis-Evensen, E.; Vatn, M.H.; Almendingen, K. Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients. J. Oncol. 2012, 2012, 254801. [CrossRef] [PubMed]
46. Thomas, G.C. Apoptosis and cancer: The genesis of a research field. Nature Rev. Cancer 2009, 9, 501-507.
47. Logue, S.E.; Gorman, A.M.; Cleary, P.; Keogh, N.; Samali, A. Current concepts in ER stress-induced apoptosis. J. Carcinogene Mutagene 2013. [CrossRef]
48. Mengeaud, V.; Nano, J.L.; Fournel, S.; Rampal, P. Effects of eicosapentaenoic acid, -linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostaglandins Leukot. Essent. Fatty Acids 1992, 47, 313-319. [CrossRef]
49. Clarke, R.G.; Lund, E.K.; Latham, P.; Pinder, A.C.; Johnson, I.T. Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. Lipids 1999, 34, 1287-1295. [CrossRef] [PubMed]
50. Chen, Z.Y.; Istfan, N.W. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukot. Essent. Fatty Acids 2000, 63, 301-308. [CrossRef] [PubMed]
51. Kubota, H.; Matsumoto, H.; Higashida, M.; Murakami, H.; Nakashima, H.; Oka, Y.; Okumura, H.; Yamamura, M.; Nakamura, M.; Hirai, T. Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line. Anticancer Res. 2013, 33, 4319-4324. [PubMed]
52. Lee, S.E.; Lim, J.W.; Kim, H. Activator protein-1 mediates docosahexaenoic acid-induced apoptosis of human gastric cancer cells. Ann. N. Y. Acad. Sci. 2009, 1171, 163-169. [CrossRef] [PubMed]
53. Lim, K.; Han, C.; Dai, Y.; Shenm, M.;Wu, T. ω-3 Polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2. Mol. Cancer Ther. 2009, 8, 3046-3055. [CrossRef] [PubMed]
54. Sun, S.N.; Jia, W.D.; Chen, H.; Ma, J.L.; Ge, Y.S.; Yu, J.H.; Li, J.S. Docosahexaenoic acid (DHA) induces apoptosis in human hepatocellular carcinoma cells. Int. J. of Clin. Exp. Pathol. 2013, 6, 281-289.
55. Zhang, Y.; Han, L.; Qi,W.; Cheng, D.; Ma, X.; Hou, L.; Cao, X.;Wang, C. Eicosapentaenoic acid (EPA) induced apoptosis in HepG2 cells through ROS-Ca2+-JNK mitochondrial pathways. Biochem. Biophys. Res. Commun. 2015, 456, 926-932. [CrossRef] [PubMed]
56. Hawkins, R.A.; Sangster, K.; Arends, M.J. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J. Pathol. 1998, 185, 61-70. [CrossRef]
57. Merendino, N.; Loppi, B.; D'Aquino, M.; Molinari, R.; Pessina, G.; Romano, C.; Velotti, F. Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutr. Cancer 2005, 52, 225-233. [CrossRef] [PubMed]
58. Fukui, M.; Kang, K.S.; Okada, K.; Zhu, B.T. EPA, an ω-3 Fatty acid, induces apoptosis in human pancreatic cancer cells: Role of ROS accumulation, caspase-8 activation, and autophagy induction. J. Cell. Biochem. 2013, 114, 192-203. [CrossRef] [PubMed]
59. Lim, K.; Han, C.; Xu, L.; Isse, K.; Demetris, A.J.; Wu, T. Cyclooxygenase-2-derived prostaglandin E2 activates β-catenin in human cholangiocarcinoma cells: Evidence for inhibition of these signaling pathways by ω 3 polyunsaturated fatty acids. Cancer Res. 2008, 68, 553-560. [CrossRef] [PubMed]
60. Rose, D.P.; Connolly, J.M. Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res. 1990, 50, 7139-7144. [PubMed]
61. Chamras, H.; Ardashian, A.; Heber, D.; Glaspy, J.A. Fatty acid modulation of MCF-7 human breast cancer cell proliferation, apoptosis and differentiation. J. Nutr. Biochem. 2002, 13, 711-716. [CrossRef]
62. Sharma, A.; Belna, J.; Logan, J.; Espat, J.; Hurteau, J.A. The effects of ω-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines. Gynecol. Oncol. 2005, 99, 58-64. [CrossRef] [PubMed]
63. Narayanan, N.K.; Narayanan, B.A.; Reddy, B.S. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kB, and steroid hormone receptors. Int. J. Oncol. 2005, 26, 785-792. [CrossRef] [PubMed]
64. Hu, Y.; Sun, H.; Owens, R.T.; Gu, Z.; Wu, J.; Chen, Y.Q.; O'Flaherty, J.T.; Edwards, I.J. Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer. Neoplasia 2010, 12, 826-836. [CrossRef] [PubMed]
65. Molinari, R.; D'Eliseo, D.; Manzi, L.; Zolla, L.; Velotti, F.; Merendino, N. The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure. Cancer Immunol. Immunother. 2011, 60, 1503-1507. [CrossRef] [PubMed]
66. Lindskog, M.; Gleissman, H.; Ponthan, F.; Castro, J.; Kogner, P.; Johnsen, J.I. Neuroblastoma cell death in response to docosahexaenoic acid: Sensitization to chemotherapy and arsenic induced oxidative stress. Int. J. Cancer 2006, 118, 2584-2593. [CrossRef] [PubMed]
67. Faragó, N.; Fehér, L.Z.; Kitajka, K.; Das, U.N.; Puskás, L.G. MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes. Lipids Health Dis. 2011, 10, 173. [CrossRef] [PubMed]
68. Serini, S.; Trombino, S.; Oliva, F.; Piccioni, E.; Monego, G.; Resci, F.; Boninsegna, A.; Picci, N.; Ranelletti, F.O.; Calviello, G. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression. Apoptosis 2008, 13, 1172-1183. [CrossRef] [PubMed]
69. Yao, Q.H.; Zhang, X.C.; Fu, T.; Gu, J.Z.;Wang, L.;Wang, Y.; Lai, Y.B.;Wang, Y.Q.; Guo, Y. ω-3 polyunsaturated fatty acids inhibit the proliferation of the lung adenocarcinoma cell line A549 in vitro. Mol. Med. Rep. 2014, 9, 401-406. [PubMed]
70. Albino, A.P.; Juan, G.; Traganos, F.; Reinhart, L.; Connolly, J.; Rose, D.P.; Darzynkiewicz, Z. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: Association with decreased pRb phosphorylation. Cancer Res. 2000, 60, 4139-4145. [PubMed]
71. Denkins, Y.; Kempf, D.; Ferniz, M.; Nileshwar, S.; Marchetti, D. Role of ω-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma. J. Lipid Res. 2005, 46, 1278-1284. [CrossRef] [PubMed]
72. Finstad, H.S.; Myhrstad, M.C.; Heimli, H.; Lømo, J.; Blomhoff, H.K.; Kolset, S.O.; Drevon, C.A. Multiplication and death-type of leukemia cell lines exposed to very long-chain polyunsaturated fatty acids. Leukemia 1998, 12, 921-929. [CrossRef] [PubMed]
73. Finstad, H.S.; Drevon, C.A.; Kulseth, M.A.; Synstad, A.V.; Knudsen, E.; Kolset, S.O. Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid. Biochem. J. 1998, 336, 451-459. [CrossRef] [PubMed]
74. Chiu, L.C.M.; Wan, J.M.F. Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of BCL-2 expression. Cancer Letters 1999, 145, 17-27. [CrossRef]
75. Chiu, L.C.; Wong, E.Y.; Ooi, V.E. Docosahexaenoic acid modulates different genes in cell cycle and apoptosis to control growth of human leukemia HL-60 cells. Int J Oncol. 2004, 25, 737-744. [CrossRef] [PubMed]
76. Siddiqui, R.A.; Jenski, L.J.; Neff, K.; Harvey, K.; Kovacs, R.J.; Stillwell, W. Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process. Biochim. Biophys. Acta 2001, 1499, 265-275. [CrossRef]
77. Zand, H.; Rhimipour, A.; Bakhshayesh, M.; Shafiee, M.; Nour Mohammadi, I.; Salimi, S. Involvement of PPAR- and p53 in DHA-induced apoptosis in Reh cells. Mol. Cell. Biochem. 2007, 304, 71-77. [CrossRef] [PubMed]
78. Yamagami, T.; Porada, C.D.; Pardini, R.S.; Zanjani, E.D.; Almeida-Porada, G. Docosahexaenoic acid induces dose dependent cell death in an early undifferentiated subtype of acute myeloid leukemia cell line. Cancer Biol. Ther. 2009, 8, 331-337. [CrossRef] [PubMed]
79. Sravan Kumar, G.; Das, U.N. Cytotoxic action of α-linolenic and eicosapentaenoic acids on myeloma cells in vitro. Prostaglandins Leukot. Essent. Fatty Acids 1997, 56, 285-293. [CrossRef]
80. Ricci-Vitiani, L.; Lombardi, D.G.; Pilozzi, E.; Biffoni, M.; Todaro, M.; Peschle, C.; de Maria, R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445, 111-115. [CrossRef] [PubMed]
81. Das, U.N. Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis. Cancer Metastasis Rev. 2011, 30, 311-324. [CrossRef] [PubMed]
82. Yang, T.; Fang, S.; Zhang, H.X.; Xu, L.X.; Zhang, Z.Q.; Yuan, K.T.; Xue, C.L.; Yu, H.L.; Zhang, S.; Li, Y.F.; et al. n-3 PUFA shave antiproliferative and apoptotic effects on human colorectal cancer stemlike cells in vitro. J. Nutr. Biochem. 2013, 24, 744-753. [CrossRef] [PubMed]
83. Vasudevan, A.; Yu, Y.; Banerjee, S.; Woods, J.; Farhana, L.; Rajendra, S.G.; Patel, A.; Dyson, G.; Levi, E.; Maddipati, K.R.; et al. ω-3 Fatty acid is a potential preventive agent for recurrent colon cancer. Cancer Prev. Res. 2014, 7, 1138-1148. [CrossRef] [PubMed]
84. De Carlo, F.; Witte, T.R.; Hardman, W.E.; Claudio, P.P. ω-3 Eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy. PLoS ONE 2013, 8, e69760.
85. Xiong, A.; Yu, W.; Liu, Y.; Sanders, B.G.; Kline, K. Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or tocotrienol through SHP-1 inhibition of Stat3 signaling. Mol. Carcinog. 2015. [CrossRef] [PubMed]
86. Rose, D.P.; Connolly, J.M.; Rayburn, J.; Coleman, M. Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J. Natl. Cancer Inst. 1995, 87, 587-592. [CrossRef] [PubMed]
87. Yam, D.; Peled, A.; Huszar, M.; Shinitzky, M. Dietary fish oil suppresses tumor growth and metastasis of Lewis lung carcinoma in mice. J. Nutr. Biochem. 1997, 8, 619-622. [CrossRef]
88. Boudreau, M.D.; Sohn, K.H.; Rhee, S.H.; Lee, S.W.; Hunt, J.D.; Hwang, D.H. Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: Mediation through cyclooxygenase-independent pathways. Cancer Res. 2001, 61, 1386-1391. [PubMed]
89. Kato, T.; Hancock, R.L.; Mohammadpour, H.; McGregor, B.; Manalo, P.; Khaiboullina, S.; Hall, M.R.; Pardini, L.; Pardini, R.S. Influence of ω-3 fatty acids on the growth of human colon carcinoma in nude mice. Cancer Lett. 2002, 187, 169-177. [CrossRef]
90. Camargo, C.Q.; Mocellin, M.C.; Pastore Silva, J.A.; de Souza Fabre, M.E.; Nunes, E.A.; de Moraes Trinidade, E.B. Fish oil supplementation during chemotherapy increases posterior time to tumor progression in colorectal cancer. Nutr. Cancer, (in press). Available online: http://.doi.org/10.1080/ 01635581.2016.1115097 (accessed on 19 January 2016).
91. Bougnoux, P.; Hajjaji, N.; Ferrasson, M.N.; Giraudeau, B.; Couet, C.; le Floch, O. Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: A phase II trial. Br. J. Cancer 2009, 1011978-1011985. [CrossRef] [PubMed]
92. Cockbain, J.; Toogood, G.J.; Hull, M.A. ω-3 Polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut 2012, 61, 135-149. [CrossRef] [PubMed]
93. Murphy, R.A.; Mourtzakis, M.; Chu, Q.S.; Baracos, V.E.; Reiman, T.; Mazurak, V.C. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced non-small cell lung cancer. Cancer 2011, 117, 3774-3780. [CrossRef] [PubMed]
94. Patterson, R.E.; Flatt, S.W.; Newman, V.A.; Natarajan, L.; Rock, C.L.; Thomson, C.A.; Caan, B.J.; Parker, B.A.; Pierce, J.P. Marine fatty acid intake is associated with breast cancer prognosis. J. Nutr. 2011, 141, 201-206. [CrossRef] [PubMed]
95. Cockbain, A.J.; Volpato, M.; Race, A.D.; Munarini, A.; Fazio, C.; Belluzzi, A.; Loadman, P.M.; Toogood, G.J.; Hull, M.A. Anticolorectal cancer activity of the ω-3 polyunsaturated fatty acid eicosapentaenoic acid. Gut 2014, 63, 1760-1768. [CrossRef] [PubMed]
96. Sánchez-Lara, K.; Turcott, J.G.; Juárez-Hernández, E.; Nuñez-Valencia, C.; Villanueva, G.; Guevara, P.; de la Torre-Vallejo, M.; Mohar, A.; Arrieta, O. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: Randomised trial. Clin. Nutr. 2014, 33, 1017-1023. [CrossRef] [PubMed]
97. Arshad, A.; Chung, W.Y.; Isherwood, J.; Mann, C.D.; Al-Leswas, D.; Steward, W.P.; Metcalfe, M.S.; Dennison, A.R. Cellular and plasma uptake of parenteral ω-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer. Clin. Nutr. 2014, 33, 895-899. [CrossRef] [PubMed]
98. Ma, Y.J.; Yu, J.; Xiao, J.; Cao, B.W. The consumption of ω-3 polyunsaturated fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: A systematic evaluation. Nutr. Cancer 2015, 67, 112-118. [CrossRef] [PubMed]
99. Nabavi, S.F.; Bilottom, S.; Russom, G.L.; Orhan, I.E.; Habtemariam, S.; Daglia, M.; Devi, K.P.; Loizzo, M.R.; Tundis, R.; Nabavi, S.M. ω-3 polyunsaturated fatty acids and cancer: Lessons learned from clinical trials. Cancer Metastasis Rev. 2015, 34, 359-380. [CrossRef] [PubMed]
100. Khankari, N.K.; Bradshaw, P.T.; Steck, S.E.; He, K.; Olshan, A.F.; Shen, J.; Ahn, J.; Chen, Y.; Ahsan, H.; Terry, M.B.; et al. Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York. Cancer 2015. [CrossRef] [PubMed]
101. Mocellin, M.C.; Camargo, C.Q.; Nunes, E.A.; Fiates, G.M.; Trindade, E.B. A systematic review and meta-analysis of the n-3 polyunsaturated fatty acids effects on inflammatory markers in colorectal cancer. Clin. Nutr. 2015. [CrossRef] [PubMed]
102. Heimli, H.; Giske, C.; Naderi, S.; Drevon, C.A.; Hollung, K. Eicosapentaenoic acid promotes apoptosis in Ramos cells via activation of caspase-3 and -9. Lipids 2002, 37, 797-802. [CrossRef] [PubMed]
103. Llor, X.; Pons, E.; Roca, A.; Alvarez, M.; Mañé, J.; Fernández-Bañares, F.; Gassull, M.A. The effects of fish oil, olive oil, oleic acid and linoleic acid on colorectal neoplastic processes. Clin. Nutr. 2003, 22, 71-79. [CrossRef] [PubMed]
104. Danbara, N.; Yuri, T.; Tsujita-Kyutoku, M.; Sato, M.; Senzaki, H.; Takada, H.; Hada, T.; Miyazawa, T.; Okazaki, K.; Tsubura, A. Conjugated docosahexaenoic acid is a potent inducer of cell cycle arrest and apoptosis and inhibits growth of colo 201 human colon cancer cells. Nutr. Cancer 2004, 50, 71-79. [CrossRef] [PubMed]
105. Calviello, G.; Di Nicuolo, F.; Serini, S.; Piccioni, E.; Boninsegna, A.; Maggiano, N.; Ranelletti, F.O.; Palozza, P. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil. Cancer Chemother. Pharmacol. 2005, 55, 12-20. [CrossRef] [PubMed]
106. Jakobsen, C.H.; Størvold, G.L.; Bremseth, H.; Follestad, T.; Sand, K.; Mack, M.; Olsen, K.S.; Lundemo, A.G.; Iversen, J.G.; Krokan, H.E.; et al. DHA induces ER stress and growth arrest in human colon cancer cells: Associations with cholesterol and calcium homeostasis. J. Lipid. Res. 2008, 49, 2089-2100. [CrossRef] [PubMed]
107. Arita, K.; Kobuchi, H.; Utsumi, T.; Takehara, Y.; Akiyama, J.; Horton, A.A.; Utsumi, K. Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. Biochem. Pharmacol. 2001, 62, 821-828. [CrossRef]
108. Narayanan, B.A.; Narayanan, N.K.; Reddy, B.S. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int. J. Oncol. 2001, 19, 1255-1262. [CrossRef] [PubMed]
109. Kolch, W.; Halasz, M.; Granovskaya, M.; Kholodenko, B.N. The dynamic control of signal transduction networks in cancer cells. Nat. Rev. Cancer 2015, 15, 515-527. [CrossRef] [PubMed]
110. Huang, C.Y.; Yu, L.C. Pathophysiological mechanisms of death resistance in colorectal carcinoma. World J. Gastroenterol. 2015, 21, 11777-11792. [CrossRef] [PubMed]
111. Glatz, J.F.; Luiken, J.J.; van Nieuwenhoven, F.A.; van der Vusse, G.J. Molecular mechanism of cellular uptake and intracellular translocation of fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 1997, 57, 3-9. [CrossRef]
112. Wassall, S.R.; Stillwell, W. Polyunsaturated fatty acid-cholesterol interactions: Domain formation in membranes. Biochim. Biophys. Acta 2009, 1788, 24-32. [CrossRef] [PubMed]
113. Zhang, C.; Yu, H.; Ni, X.; Shen, S.; Das, U.N. Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes. PLoS ONE 2015, 10, e0123256.
114. Ibarguren, M.; López, D.J.; Escribá, P.V. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochim. Biophys. Acta 2014, 1838, 1518-1528. [CrossRef] [PubMed]
115. Corsetto, P.A.; Cremona, A.; Montorfano, G.; Jovenitti, I.E.; Orsini, F.; Arosio, P.; Rizzo, A.M. Chemical-physical changes in cell membrane microdomains of breast cancer cells after ω-3 PUFA incorporation. Cell Biochem. Biophys. 2012, 64, 45-59. [CrossRef] [PubMed]
116. Schley, P.D.; Brindley, D.N.; Field, C.J. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J. Nutr. 2007, 137, 548-553. [PubMed]
117. Rogers, K.R.; Kikawa, K.D.; Mouradian, M.; Hernandez, K.; McKinnon, K.M.; Ahwah, S.M.; Pardini, R.S. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association. Carcinogenesis 2010, 31, 1523-1530. [CrossRef] [PubMed]
118. Corsetto, P.A.; Montorfano, G.; Zava, S.; Jovenitti, I.E.; Cremona, A.; Berra, B.; Rizzo, A.M. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis. 2011, 10, 73 [CrossRef] [PubMed]
119. Lee, E.J.; Yun, U.J.; Koo, K.H.; Sung, J.Y.; Shim, J.; Ye, S.K.; Hong, K.M.; Kim, Y.N. Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis. Biochim. Biophys. Acta 2014, 1841, 190-203. [CrossRef] [PubMed]
120. Mason, J.K.; Klaire, S.; Kharotia, S.;Wiggins, A.K.; Thompson, L.U. α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways. Lipids Health Dis. 2015, 14, 91. [CrossRef] [PubMed]
121. Cao,W.; Ma, Z.; Rasenick, M.M.; Yeh, S.; Yu, J. n-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth. PLoS ONE 2012, 7, e52838. [CrossRef] [PubMed]
122. Ewaschuk, J.B.; Newell, M.; Field, C.J. Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER- breast cancer cells. Lipids 2012, 47, 1019-1030. [CrossRef] [PubMed]
123. Gu, Z.;Wu, J.;Wang, S.; Suburu, J.; Chen, H.; Thomas, M.J.; Shi, L.; Edwards, I.J.; Berquin, I.M.; Chen, Y.Q. Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells. Carcinogenesis 2013, 34, 1968-1975. [CrossRef] [PubMed]
124. Calviello, G.; Resci, F.; Serini, S.; Piccioni, E.; Toesca, A.; Boninsegna, A.; Monego, G.; Ranelletti, F.O.; Palozza, P. Docosahexaenoic acid induces proteasome-dependent degradation of β-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis 2007, 28, 1202-1209. [CrossRef] [PubMed]
125. Song, K.S.; Jing, K.; Kim, J.S.; Yun, E.J.; Shin, S.; Seo, K.S.; Park, J.H.; Heo, J.Y.; Kang, J.X.; Suh, K.S.; et al. w-3-Polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/β-catenin signaling. Pancreatology 2011, 11, 574-584. [CrossRef] [PubMed]
126. Xue, M.; Wang, Q.; Zhao, J.; Dong, L.; Ge, Y.; Hou, L.; Liu, Y.; Zheng, Z. Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo. J. Nutr. Biochem. 2014, 25, 104-110. [CrossRef] [PubMed]
127. Sun, H.; Hu, Y.; Gu, Z.; Owens, R.T.; Chen, Y.Q.; Edwards, I.J. ω-3 Fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. Carcinogenesis 2011, 32, 1518-1524. [CrossRef] [PubMed]
128. Schley, P.D.; Jijon, H.B.; Robinson, L.E.; Field, C.J. Mechanisms of ω-3 fatty acid-induced growth inhibition in MDAMB-231 human breast cancer cells. Breast Cancer Res. Treat. 2005, 92, 187-195. [CrossRef] [PubMed]
129. Ghosh-Choudhury, T.; Mandal, C.C.; Woodruff, K.; St Clair, P.; Fernandes, G.; Choudhury, G.G.; Ghosh-Choudhury, N. Fish oil targets PTEN to regulate NFκB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res. Treat. 2009, 118, 213-228. [CrossRef] [PubMed]
130. Engelbrecht, A.M.; Toit-Kohn, J.L.; Ellis, B.; Thomas, M.; Nell, T.; Smith, R. Differential induction of apoptosis and inhibition of the PI3-kinase pathway by saturated, monounsaturated and polyunsaturated fatty acids in a colon cancer cell model. Apoptosis 2008, 13, 1368-1377. [CrossRef] [PubMed]
131. Jing, K.; Song, K.S.; Shin, S.; Kim, N.; Jeong, S.; Oh, H.R.; Park, J.H.; Seo, K.S.; Heo, J.Y.; Han, J.; et al. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy 2011, 7, 1348-1358. [CrossRef] [PubMed]
132. Shin, S.; Jing, K.; Jeong, S.; Kim, N.; Song, K.S.; Heo, J.Y.; Park, J.H.; Seo, K.S.; Han, J.; Park, J.I.; et al. The ω-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53. Biomed. Res. Int. 2013, 2013, 568671. [CrossRef] [PubMed]
133. Kim, N.; Jeong, S.; Jing, K.; Shin, S.; Kim, S.; Heo, J.Y.; Kweon, G.R.; Park, S.K.; Wu, T.; Park, J.I.; et al. Docosahexaenoic acid induces cell death in human non-small cell Lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition. Biomed. Res. Int. 2015, 2015, 239764. [CrossRef] [PubMed]
134. Rescigno, T.; Capasso, A.; Tecce, M.F. Effect of Docosahexaenoic acid on cell cycle pathways in Breast cell lines with different transformation degree. J. Cell. Physiol. 2015. [CrossRef] [PubMed]
135. Shaikh, I.A.; Brown, I.; Schofield, A.C.; Wahle, K.W.; Heys, S.D. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: The role of genes associated with the NF-κB pathway. Prostate 2008, 68, 1635-1646. [CrossRef] [PubMed]
136. Cavazos, D.A.; Price, R.S.; Apte, S.S.; de Graffenried, L.A. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. Prostate 2011, 71, 1420-1428. [CrossRef] [PubMed]
137. Jeong, S.; Jing, K.; Kim, N.; Shin, S.; Kim, S.; Song, K.S.; Heo, J.Y.; Park, J.H.; Seo, K.S.; Han, J.; et al. Docosahexaenoic acid-induced apoptosis is mediated by activation of mitogen-activated protein kinases in human cancer cells. BMC Cancer 2014, 14, 481. [CrossRef] [PubMed]
138. Gleissman, H.; Yang, R.; Martinod, K.; Lindskog, M.; Serhan, C.N.; Johnsen, J.I.; Kogner, P. Docosahexaenoic acid metabolome in neural tumors: Identification of cytotoxic intermediates. FASEB J. 2010, 24, 906-915. [CrossRef] [PubMed]
139. Serhan, C.N.; Arita, M.; Hong, S.; Gotlinger, K. Resolvins, docosatrienes, and neuroprotectins, novel ω-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004, 39, 1125-1132. [CrossRef] [PubMed]
140. Hong, S.; Lu, Y.; Yang, R.; Gotlinger, K.H.; Petasis, N.A.; Serhan, C.N. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J. Am. Soc. Mass Spectrom. 2007, 18, 128-144. [CrossRef] [PubMed]
141. Ding, W.Q.; Vaught, J.L.; Yamauchi, H.; Lind, S.E. Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: The potential importance of down-regulation of superoxide dismutase 1 expression. Mol. Cancer Ther. 2004, 3, 1109-1117. [PubMed]
142. Ding, W.Q.; Lind, S.E. Phospholipid hydroperoxide glutathione peroxidase plays a role in protecting cancer cells from docosahexaenoic acid-induced cytotoxicity. Mol. Cancer Ther. 2007, 6, 1467-1474. [CrossRef] [PubMed]
143. Vibet, S.; Goupille, C.; Bougnoux, P.; Steghens, J.P.; Goré, J.; Mahéo, K. Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response. Free Radic. Biol. Med. 2008, 44, 1483-1491. [CrossRef] [PubMed]
144. Sturlan, S.; Baumgartner, M.; Roth, E.; Bachleitner-Hofmann, T. Docosahexaenoic acid enhances arsenic trioxidemediated apoptosis in arsenic trioxide-resistant HL-60 cells. Blood 2003, 101, 4990-4997. [CrossRef] [PubMed]
145. Granci, V.; Cai, F.; Lecumberri, E.; Clerc, A.; Dupertuis, Y.M.; Pichar, C. Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway. Br. J. Nutr. 2013, 109, 1188-1195. [CrossRef] [PubMed]
146. Hossain, Z.; Hosokawa, M.; Takahashi, K. Growth inhibition and induction of apoptosis of colon cancer cell lines by applying marine phospholipid. Nutrition and Cancer 2009, 61, 123-130. [CrossRef] [PubMed]
147. Dai, J.; Shen, J.; Pan,W.; Shen, S.; Das, U.N. Effects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro. Lipids Health Dis. 2013, 12, 71. [CrossRef] [PubMed]
148. Jing, K.; Shin, S.; Jeong, S.; Kim, S.; Song, K.S.; Park, J.H.; Heo, J.Y.; Seo, K.S.; Park, S.K.; Kweon, G.R.; et al. Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin-proteasome system. Cell Death Dis. 2014, 5, e1524. [CrossRef] [PubMed]
149. Kang, K.S.;Wang, P.; Yamabe, N.; Fukui, M.; Jay, T.; Zhu, B.T. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS ONE 2010, 5, e10296. [CrossRef] [PubMed]
150. Zajdel, A.;Wilczok, A.; Tarkowski, M. Toxic effects of n-3 polyunsaturated fatty acids in human lung A549 cells. Toxicol. Vitro 2015. [CrossRef] [PubMed]
151. Serhan, C.N.; Hong, S.; Gronert, K.; Colgan, S.P.; Devchand, P.R.; Mirick, G.; Moussignac, R.L. Resolvins: A family of bioactive products of ω-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 2002, 196, 1025-1037. [CrossRef] [PubMed]
152. Wang, Q.; Hu, M.; Xu, H.; Yang, X. Anti-inflammatory and Pro-resolving effects of n-3 PUFA in Cancers: Structures and Mechanisms. Curr. Top Med. Chem. 2016, 16, 888-894. [CrossRef] [PubMed]
153. Hawcroft, G.; Loadman, P.M.; Belluzzi, A.; Hull, M.A. Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells. Neoplasia 2010, 12, 618-627. [CrossRef] [PubMed]
154. Poorani, R.; Bhatt, A.N.; Dwarakanath, B.S.; Das, U.N. COX-2, aspirin and metabolism of arachidonic, eicosapentaenoic and docosahexaenoic acids and their physiological and clinical significance. Eur. J. Pharmacol. 2015. [CrossRef] [PubMed]
155. Karmali, R.A.; Reichel, P.; Cohen, L.A.; Terano, T.; Hirai, A.; Tamura, Y.; Yoshida, S. The effects of dietary w-3 fatty acids on the DU-145 transplantable human prostatic tumor. Anticancer Res. 1987, 17, 1173-1180.
156. Rose, D.P.; Cohen, L.A. Effects of dietary menhaden oil and retinyl acetate on the growth of DU145 human prostatic adenocarcinoma cells transplanted into athymic nude mice. Carcinogenesis 1988, 9, 603-605. [CrossRef] [PubMed]
157. Rose, D.P.; Connolly, J.M. Dietary fat and breast cancer metastasis by human tumor xenografts. Breast Cancer Res. Treat. 1997, 46, 225-237. [CrossRef] [PubMed]
158. Kobayashi, N.; Barnard, R.J.; Henning, S.M.; Elashoff, D.; Reddy, S.T.; Cohen, P.; Leung, P.; Hong-Gonzalez, J.; Freedland, S.J.; Said, J.; et al. Effect of altering dietary ω-6/ω-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin. Cancer Res. 2006, 12, 4662-4670. [CrossRef] [PubMed]
159. Funahashi, H.; Satake, M.; Hasan, S.; Sawai, H.; Newman, R.A.; Reber, H.A.; Hines, O.J.; Eibl, G. Opposing effects of n-6 and n-3 polyunsaturated fatty acids on pancreatic cancer growth. Pancreas 2008, 36, 353-362. [CrossRef] [PubMed]
160. Narayanan, B.A.; Narayanan, N.K.; Desai, D.; Pittman, B.; Reddy, B.S. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and β-catenin pathways in colon cancer cells. Carcinogenesis 2004, 25, 2443-2449. [CrossRef] [PubMed]
161. Calviello, G.; Serini, S.; Piccioni, E. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: Molecular mechanisms involved. Curr. Med. Chem. 2007, 14, 3059-3069. [CrossRef] [PubMed]
162. Sun, H.; Berquin, I.M.; Owens, R.T.; O'Flaherty, J.T.; Edwards, I.J. Peroxisome proliferator-activated receptor -mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells. Cancer Res. 2008, 68, 2912-2919. [CrossRef] [PubMed]
163. Edwards, I.J.; Sun, H.; Hu, Y.; Berquin, I.M.; O'Flaherty, J.T.; Cline, J.M.; Rudel, L.L.; Chen, Y.Q. In vivo and in vitro regulation of syndecan 1 in prostate cells by n-3 polyunsaturated fatty acids. J. Biol. Chem. 2008, 283, 18441-18449. [CrossRef] [PubMed]
164. O'Flaherty, J.T.; Hu, Y.; Wooten, R.E.; Horita, D.A.; Samuel, M.P.; Thomas, M.J.; Sun, H.; Edwards, I.J. 15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival. PLoS ONE 2012, 7, e45480. [CrossRef] [PubMed]
165. Hu, Y.; Sun, H.; O'Flaherty, J.T.; Edwards, I.J. 15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells. Carcinogenesis 2013, 34, 176-182. [CrossRef] [PubMed]
166. Zou, S.; Meng, X.; Meng, Y.; Liu, J.; Liu, B.; Zhang, S.; Ding, W.; Wu, J.; Zhou, J. Microarray analysis of anti-cancer effects of docosahexaenoic acid on human colon cancer model in nude mice. Int. J. Clin. Exp. Med. 2015, 8, 5075-5084. [PubMed]
167. Sheng, H.; Li, P.; Chen, X.; Liu, B.; Zhu, Z.; Cao,W. ω-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1. Front. Biosci. 2014, 19, 854-861. [CrossRef]